《2019冠状病毒病与终末期肾病：快速综述》

COVID-19 and ESKD, A Rapid Review.

作者信息

Shah Ankur D, Calabro-Kailukaitis Nathan

机构信息

Alpert Medical School of Brown University, Providence, RI; Division of Kidney Disease and Hypertension, Rhode Island Hospital; Division of Nephrology, Medicine Service, Providence Veterans Affairs Medical Center, Providence, RI.

Alpert Medical School of Brown University; Division of Kidney Disease and Hypertension, Rhode Island Hospital, Providence, RI.

出版信息

R I Med J (2013). 2020 Sep 4;103(8):29-33.

PMID:32900009

Abstract

In 2020, the COVID-19 pandemic has ravaged the world. Individuals with end-stage kidney disease (ESKD) are at higher risk due to impaired immunity, comorbid conditions, and dependence on travel to medical care settings. We review the salient features of COVID-19 in this population, including the risk of infection, disease course, changes in dialysis unit management, use of investigatory medications, access considerations, home dialysis, and capacity planning.

摘要

2020年，新型冠状病毒肺炎疫情肆虐全球。终末期肾病（ESKD）患者由于免疫力受损、合并症以及依赖前往医疗机构就诊，面临更高的风险。我们回顾了该人群中新型冠状病毒肺炎的显著特征，包括感染风险、病程、透析单元管理的变化、研究性药物的使用、就医便利性考量、家庭透析以及能力规划。